Atomera Incorporated vs Stryker Corporation — how do they compare? Atomera Incorporated trades at $6.48 (market cap $247.40M), while Stryker Corporation trades at $312.5 (market cap $119.25B). The key difference: Stryker Corporation is far larger — about 482× Atomera Incorporated's market cap, and Stryker Corporation pays a 1.13% dividend while Atomera Incorporated pays none. Which is the better fit depends on your goals.
| ATOM | SYK | |
|---|---|---|
Market Cap | $247.40M | $119.25B |
Sector | Technology | Technology |
52-Week High | $12.11 | $403.53 |
52-Week Low | $1.99 | $282.58 |
Enterprise Value | $207.61M | $131.01B |
Dividend Yield | — | 1.13% |
Signals from Pluang's Aura AI — not financial advice
ATOM trades at $6.25, down 5.73% over 24 hours, reflecting a bearish technical outlook with negative earnings trends. The company reported a net loss of $20.17 million in 2025 on minimal revenue of $65,000, with profitability metrics deeply negative. Recent news highlights Atomera's focus on semiconductor technology advancements, including GaN-on-Silicon collaborations, but financial performance remains a significant concern.
The outlook is cautious due to persistent losses and weak revenue, though analyst consensus is unanimously bullish with a 100% buy rating. Key risks include execution challenges in monetizing technology and high cash burn. Upside depends on successful commercialization of its semiconductor IP, but current fundamentals suggest high volatility and substantial shareholder risk.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →